Financials

News Ideas Discussions Technicals Forecast Seasonals

MYGN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Myriad Genetics, Inc.

Total assets of MYGN for Q2 24 is 1.09 B USD, 2.29% less than the previous Q1 24. And total liabilities decreased by 1.68% in Q2 24 to 344.6 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—